The NHLBI and NIDDK are seeking high quality collaborative proposals for the RO1 opportunity described below. The Daniella Foundation hopes each of you will consider developing submissions to meet the Institute’s interest in expanding critical research in this area.
Update and Reminder for the NHLBI and NIDDK sponsored Ribosomal Disorders and Their Role in Inherited Bone Marrow Failure Syndromes (R01).
We’re happy to report that the NHLBI funding line for this RO1 has been nearly doubled and is now being funded at 11% instead of 6% with Early-Stage Investigators receiving up to an additional 10 percentile points. The NIDDK’s funding line will continue at 11% with an additional 5 percentile points offered to Early-State Investigators!
This program announcement encourages applications from institutions/organizations that propose collaborative research projects by multi-disciplinary teams to advance our understanding of molecular and cellular mechanisms underlying ribosomal dysfunction. These research areas include effects on hematopoiesis and their role in bone marrow failure syndromes. Multi-disciplinary expertise across basic and clinical components is encouraged. To meet the objectives of this FOA applicants are encouraged to integrate ribosomal biology with bone marrow failure to develop and characterize models of ribosomopathies.
A full synopsis of this Program Announcement FOA Number: PA-11-121 can be viewed by clicking here.